45
Participants
Start Date
December 31, 2025
Primary Completion Date
December 31, 2030
Study Completion Date
December 31, 2030
Active Surveillance
Following systemic therapy, participants will undergo active surveillance with brain MRI every 3 months. Radiation therapy will only be initiated if disease progression is observed on imaging, at the discretion of the treating physician.
University of Vermont Medical Center, Burlington
University of Vermont Medical Center
OTHER